John Wiley Sons Cl A (WLY) AI Stock Analysis

• Market Cap: $2.31B
• Dividend Yield: 3.28%
• Average Volume (3M): 482.09K
• Price to Earnings (P/E): 57.7
• Beta (1Y): 0.59
• Revenue Growth: -11.77%
• EPS Growth: N/A
• Country: US
• Employees: 6,400
• Sector: Communication Services
• Sector Strength: 75
• Industry: Publishing
• EPS (TTM): 0.74
• Shares Outstanding: 44,892,857
• 10 Day Avg. Volume: 393,497
• 30 Day Avg. Volume: 482,089
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 1.40
• Price to Cash Flow (P/CF): 4.10
• P/FCF Ratio: 4.50
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Wiley's stock reflects a balanced outlook with strengths in strategic growth areas like AI licensing and research, alongside significant financial challenges. While the earnings call and corporate events suggest a positive strategic direction, high leverage and cash flow issues remain primary concerns. The technical analysis and valuation indicate moderate stock attractiveness, tempered by a high P/E ratio and mixed technical indicators.

John Wiley Sons Cl A Business Overview & Revenue Model

Company Description

John Wiley & Sons, Inc. operates as a research and education company worldwide. The company operates through three segments: Research Publishing & Platforms, Academic & Professional Learning, and Education Services. The Research Publishing & Platforms segment offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries. This segment also publishes physical sciences and engineering, health sciences, social sciences, and humanities and life sciences journals; and provides a publishing software and service for scholarly and professional societies, and publishers to deliver, host, enhance, market, and manage their content on the web through the Literatum platform. It sells and distributes its products through various channels, including research libraries and library consortia, and independent subscription agents, as well as directly to professional society members, bookstores, online booksellers, and other customers. The Academic & Professional Learning segment provides education publishing and professional learning products and services, including scientific, professional, and education print and digital books, digital courseware, and test preparation services to libraries, corporations, students, professionals, and researchers, as well as learning, development, and assessment services for businesses and professionals. This segment distributes its products through chain and online booksellers, libraries, colleges and universities, corporations, direct to consumer, websites, distributor networks, and other online applications. The Education Services segment provides online program management services for higher education institutions and talent development services including placement and training for professionals and businesses. The company was founded in 1807 and is headquartered in Hoboken, New Jersey.

How the Company Makes Money

John Wiley & Sons, Inc. generates revenue primarily through the sale of its academic and professional content. Key revenue streams include subscriptions to scientific, technical, and medical journals, sales of books and e-books, and licensing agreements for its digital content. The company also earns money through its education segment, which provides digital courseware, online education platforms, and test preparation services. Strategic partnerships with academic institutions, corporations, and government organizations, as well as a strong presence in various digital channels, significantly contribute to Wiley's earnings by expanding the reach and accessibility of its content and services.

John Wiley Sons Cl A Financial Statement Overview

Summary

John Wiley Sons Cl A faces financial challenges with declining revenues and profitability, high leverage, and negative cash flow generation. Despite some positive trends in EBIT and EBITDA margins, the overall financial health requires strategic improvements.

Income Statement

The company experienced a decline in revenue and profitability over the period analyzed. The TTM (Trailing-Twelve-Months) data shows a decrease in total revenue compared to previous years. Gross profit margin remains relatively stable, but net profit margin is low due to decreased net income. EBIT and EBITDA margins show some improvement in the TTM period but are still below historical levels.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio, indicating significant leverage. Stockholders' equity has decreased over time, impacting the equity ratio negatively. Return on equity is low due to declining net income. The company's total assets have decreased, but debt levels remain high, posing potential financial risk.

Cash Flow

The cash flow statement highlights a concerning trend with negative free cash flow in the TTM period. Operating cash flow is also negative, indicating challenges in generating cash from operations. The free cash flow to net income ratio is unfavorable, suggesting issues in translating profits into free cash flow.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
1.70B	1.87B	2.02B	2.08B	1.94B	1.83B
	Gross Profit
1.23B	1.24B	1.33B	1.38B	1.32B	1.24B
	EBIT
224.73M	52.26M	208.96M	219.28M	185.51M	194.05M
	EBITDA
321.69M	52.26M	293.60M	445.63M	395.88M	141.59M
	Net Income Common Stockholders
41.33M	-200.32M	17.23M	148.31M	148.26M	-74.29M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
112.31M	83.25M	106.71M	100.40M	93.80M	202.46M
	Total Assets
2.31B	2.73B	3.11B	3.36B	3.45B	3.17B
	Total Debt
657.00M	887.28M	883.50M	940.14M	989.86M	956.62M
	Net Debt
544.69M	804.03M	776.79M	839.75M	896.07M	754.15M
	Total Liabilities
1.45B	1.99B	2.06B	2.22B	2.36B	2.24B
	Stockholders Equity
862.36M	739.72M	1.05B	1.14B	1.09B	933.62M
Cash Flow		Free Cash Flow
151.19M	105.88M	170.38M	217.40M	226.71M	198.00M
	Operating Cash Flow
235.54M	207.64M	277.07M	339.10M	359.92M	288.44M
	Investing Cash Flow
-97.84M	-106.64M	-98.40M	-194.02M	-433.15M	-346.67M
	Financing Cash Flow
-138.50M	-107.22M	-168.57M	-131.64M	-47.09M	172.68M

John Wiley Sons Cl A Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 42.85
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WLY, the sentiment is Neutral. The current price of 42.85 is below the 20-day moving average (MA) of 43.32, above the 50-day MA of 42.31, and below the 200-day MA of 45.29, indicating a neutral trend. The MACD of -0.21 indicates Positive momentum. The RSI at 49.73 is Neutral, neither overbought nor oversold. The STOCH value of 71.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for WLY.

John Wiley Sons Cl A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RELX	79 Outperform	$96.24B	39.41	56.34%	1.48%	5.86%	13.13%
PSO	71 Outperform	$9.98B	18.97	10.99%	1.95%	-0.59%	24.06%
NYT	69 Neutral	$8.06B	27.80	15.92%	1.05%	6.59%	26.68%
SCHL	65 Neutral	$434.53M	27.32	1.92%	4.91%	-3.10%	-58.47%
ZD	64 Neutral	$1.31B	24.02	3.40%	―	2.76%	58.98%
Sector *	59 Neutral	$13.83B	7.37	-0.59%	3.89%	2.56%	-39.63%
WLY	58 Neutral	$2.31B	57.73	5.77%	3.28%	-11.77%	―

John Wiley Sons Cl A Corporate Events

John Wiley & Sons Updates CFO Compensation Plan

On March 20, 2025, John Wiley & Sons, Inc. announced changes to the compensation arrangement for Christopher Caridi, the Interim Chief Financial Officer. Effective April 1, 2025, Mr. Caridi’s annual base salary will increase to $450,000, and he will be eligible for a higher performance-based cash bonus under the Wiley Annual Incentive Plan. These changes reflect the company’s commitment to aligning executive compensation with performance and retaining key leadership during this interim period.

Wiley Appoints Dr. Karen Madden to Board

On March 5, 2025, Wiley announced the appointment of Dr. Karen N. Madden to its Board of Directors, effective February 28, 2025. Dr. Madden, who is the Senior Vice President and Chief Technology Officer at MilliporeSigma, brings extensive experience in science, technology, and innovation. Her appointment is expected to enhance Wiley’s strategic vision and innovation capabilities, aligning with the company’s commitment to advancing knowledge and delivering trusted content and services. Dr. Madden’s role on the Board and Audit Committee, along with her participation in the non-employee director compensation program, underscores Wiley’s focus on leveraging her expertise to drive progress and growth.